Related Experiment Video
Updated: Apr 19, 2026

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages
Published on: November 3, 2014
Hijacking innate immunity to enhance mRNA therapeutics by blocking IFN-P-body-XRN1 axis-mediated degradation
Tinghong Zhang1,2, Xing Peng2, Jinling Qin2,3
1State Key Laboratory of Respiratory Disease, the First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Abstract:
Innate immune activation is a major driver of unmodified in vitro-transcribed (IVT) mRNA degradation; however, how modified IVT mRNAs are degraded, and the related regulation mechanisms, remain poorly understood. Through a focused screen of viral- and host-derived immune suppressors, we identify 13 factors that enhance mRNA performance, with SOCS1 and the coronaviral membrane protein (M) emerging as the most potent. Multi-omics analyses reveal that pseudouridine-modified IVT mRNA undergoes rapid deadenylation and predominant 3'-5' decay, followed by bidirectional degradation, closely resembling endogenous mRNA decay kinetics, and is extensively associated with canonical mRNA decay machineries. Mechanistically, IVT mRNA activates IFN-β signaling, which promotes processing body (P-body) formation and XRN1-mediated 5'-3' degradation. Suppression of IFN signaling by SOCS1 or M markedly enhances mRNA expression across diverse cell types, organoid systems, and murine disease models. Together, these findings define a type I interferon-P-body-XRN1 axis that constrains modified IVT mRNA stability and provides a framework for enhancing mRNA therapeutics.
Insights
Modified in vitro-transcribed (IVT) mRNA stability is limited by the type I interferon pathway. Suppressing this signaling with factors like SOCS1 enhances mRNA performance for therapeutic applications.
Area of Science:
- Molecular Biology
- Immunology
- Biochemistry
Background:
- Innate immune activation significantly impacts unmodified in vitro-transcribed (IVT) mRNA degradation.
- Mechanisms regulating the degradation of modified IVT mRNAs are not well understood.
Purpose of the Study:
- To identify factors that enhance the performance of modified IVT mRNAs.
- To elucidate the degradation pathways and regulatory mechanisms of modified IVT mRNAs.
Main Methods:
- Screening of viral and host immune suppressors.
- Multi-omics analyses (including transcriptomics and proteomics).
- Functional assays in cell lines, organoids, and murine models.
Main Results:
- Thirteen factors enhancing mRNA performance were identified, notably SOCS1 and coronaviral M protein.
- Pseudouridine-modified IVT mRNA exhibits rapid deadenylation and 3'-5' decay, similar to endogenous mRNA.
- IVT mRNA activates IFN-β signaling, leading to P-body formation and XRN1-mediated degradation.
- SOCS1 and M protein suppress IFN signaling, significantly improving mRNA expression in various systems and disease models.
Conclusions:
- A type I interferon-P-body-XRN1 signaling axis limits modified IVT mRNA stability.
- Targeting this axis offers a strategy to enhance the stability and efficacy of mRNA therapeutics.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Types of RNA
RNA Performs Diverse...

